GlassScriptPhysician profile
Moriah R Moffitt
NPI 1124048830
$2,158.33
in general payments reported to CMS, 2019-2025
13 companies · $1,229 in 2025
The $1,229 reported for 2025 was more than what 77% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $193 · 2021: $100 · 2022: $125 · 2023: $348 · 2024: $164 · 2025: $1,229.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,740.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,740.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Motiva USA, LLC | $357.89 | 2025 | |
| Abbvie INC. | $351.62 | 2023-2025 | |
| Mentor Worldwide LLC | $201.44 | 2022-2023 | Artoura Breast Tissue Expander, Mentor Memorygel Resterilizable Gel Sizer |
| Kerecis Limited | $188.00 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Revance Therapeutics, INC. | $148.09 | 2024 | Daxxify |
| Musculoskeletal Transplant Foundation INC. | $146.73 | 2025 | |
| Merz North America, INC. | $143.85 | 2019-2021 | |
| Solventum Corporation | $141.74 | 2025 | Prevena, V.A.C.Ulta |
| Acell, INC. | $125.00 | 2019 | |
| Aroa Biosurgery Incorporated | $121.46 | 2025 | |
| Integra Lifesciences Corporation | $110.93 | 2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Tela Bio, INC. | $97.11 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Allergan, INC. | $24.47 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Moriah Moffitt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.